Technical Data
MYRIP (Myosin VIIA and Rab Interacting Protein, DKFZp586F1018, Exophilin 8, Exophilin, FLJ44025, MGC130034, MGC130035, Rab Effector MYRIP, Synaptotagmin-like Protein Homolog Lacking C2 Domains-c, Slp Homolog Lacking C2 Domains, SLAC2C, SLAC2-C)
A molecular complex composed of Rab27A, MYRIP and myosin VIIa bridges retinal melanosomes to the actin cytoskeleton and thereby mediates the local trafficking of these organelles. The defect of this molecular complex is likely to account for the perinuclear mislocalization of the melanosomes observed in the retinal pigment epithelium cells of myosin VIIa-defective mice.

Positive Control: Heart and testis extracts.

Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot Store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
PabIgGAffinity Purified
100ug-20CBlue IceHumanGoat
Synthetic peptide: KDLMEPALESAVMY representing the C-Terminus of the human protein (residues 846-859), according to NP_056275.
Purified by immunoaffinity chromatography.
Supplied as a liquid in TBS, pH 7.2, 0.5% BSA.
Species Crossreactivity: Crossreacts with Human.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
El-Amraoui A et al. MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes. EMBO Rep 3:463-70 (2002).